Unique ID issued by UMIN | UMIN000050471 |
---|---|
Receipt number | R000057485 |
Scientific Title | A study to evaluate the safety of overdose intake of plant extract materials |
Date of disclosure of the study information | 2023/03/30 |
Last modified on | 2023/07/13 23:18:48 |
Overdose safety test
Overdose safety test
A study to evaluate the safety of overdose intake of plant extract materials
A study to evaluate the safety of overdose intake of plant extract materials
Japan |
healthy person
Adult |
Others
NO
Evaluation of the Safety of plant extract materials in Overdose
Efficacy
Safety evaluation of 1000 mg of plant extract material, which is 5 times the recommended intake.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Duration: 4 weeks
Test food: plant extract materials
Dosage and administration: 10 capsules of plant extract materials 50 mg/1 capsule (20 capsules/day, 1000 mg plant extract materials/day) at breakfast and dinner.
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1) Age: Men and women who are between 20 and 65 years old (at the time of obtaining consent) and able to go to the hospital.
2) Healthy subjects (Healthy subjects in this study are defined as those who do not have any serious organ disorder or specific disease and are not receiving any related treatment or any kind of drug therapy. Whether or not a person qualifies as an able-bodied person is based on the person's declaration at the start of the examination).
3) The applicant must be able to avoid eating, drinking, and excessive exercise during the examination period, and must be able to lead the same lifestyle (eating and exercise habits, sleep, etc.) as he/she did before the examination period.
4) Those who have been fully informed of the purpose and content of the study, have the capacity to consent, and have voluntarily volunteered to participate in the study based on a good understanding of the purpose and content of the study, and who have agreed to participate in the study in writing.
1) Patients with a history of treatment for heart failure, myocardial infarction, etc.
2) Exclusion due to disease, etc. (those suffering from or undergoing treatment for atrial fibrillation, arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic disease, etc.)
3)Those whose physical measurements, physical examination values, and clinical examination values in the preliminary examination show values that are significantly out of the reference range.
4) Those who regularly use pharmaceuticals (including herbal medicines) or supplements
5) Those who have allergies (to pharmaceuticals or food related to the tested products).
6) Pregnant, lactating, or likely to become pregnant during the study period.
7) Who have participated or are currently participating in other clinical trials within one month.
8) Other subjects who are judged by the investigator to be unsuitable for this study.
22
1st name | Kazuhiko |
Middle name | |
Last name | Aida |
NIPPNCORPORATION
Innovation Center, Central Research Laboratory
2430041
5-1-3 Midorigaoka, Atsugi City, Kanagawa Prefecture
042-222-6963
kaida@nippn.co.jp
1st name | Kazuhiro |
Middle name | |
Last name | Ohno |
Clinical Creative Co., Ltd.
Pharmaceutical Development Division
0620933
1-12-102, Hiragishi 3-13-1-12, Toyohira-ku, Sapporo City, Hokkaido
09031166218
k-ohno@cli-creative.com
Clinical Creative Co., Ltd.
NIPPNCORPORATION
Self funding
Japan
Sapporo Yurinokai Hospital Clinical Trial Review Committee
11-186 Yurigahara, Kita-ku, Sapporo-shi, Hokkaido
011-771-1501
info@yurinokai.jp
NO
医療法人社団 札幌百合の会病院(北海道)
2023 | Year | 03 | Month | 30 | Day |
Unpublished
Completed
2023 | Year | 02 | Month | 15 | Day |
2023 | Year | 02 | Month | 22 | Day |
2023 | Year | 03 | Month | 30 | Day |
2023 | Year | 05 | Month | 13 | Day |
2023 | Year | 03 | Month | 02 | Day |
2023 | Year | 07 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057485
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |